Science Explorer Back to mapMap
Discussion
Researcher · Sendai Kousei Hospital · Japan

Jun Sugisaka

Jun Sugisaka publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Lung Cancer Research Studies.

ORCID 0000-0002-1000-0077 OpenAlex
World rank
#2,916,104
of 7,710,434 ranked researchers
Rank in Japan
#64,048
of 383,136
Works
63
Citations
1.1k
Citations per work
17.6
h-index
11
i10-index 13Top 54% in Oncology
Jun Sugisaka

What does Jun Sugisaka research?

Jun Sugisaka's work is mostly in Medicine (78%), Biochemistry, Genetics and Molecular Biology (5%), Immunology and Microbiology (3%).

Health Sciences: 49 works · 77.7% of their workMedicine: 49 works · 77.7% of their workOncology: 27 works · 42.4% of their workPulmonary and Respiratory Medicine: 18 works · 29.3% of their workEpidemiology: 2 works · 3.8% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 2.2% of their workEverything else: 9 works · 14.1% of their workLife Sciences: 5 works · 8.2% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 4.9% of their workMolecular Biology: 3 works · 4.9% of their workImmunology and Microbiology: 2 works · 3.3% of their workImmunology: 2 works · 3.3% of their workTHEIR WORKJun Sugisaka63works
Life Sciences8%Health Sciences78%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4977.7%
  2. Everything else914.1%
    1. Biochemistry, Genetics and Molecular Biology34.9%
    2. Immunology and Microbiology23.3%
  1. 1Oncology42% of their works
  2. 2Pulmonary and Respiratory Medicine29% of their works
  3. 3Molecular Biology5% of their works
  4. 4Epidemiology4% of their works
  5. 5Immunology3% of their works
  6. 6Radiology, Nuclear Medicine and Imaging2% of their works

Research topics

Which keywords describe Jun Sugisaka's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Tumor Microenvironment, Immune Checkpoint Blockade, PD-1 and PD-L1, Chemotherapy, ALK Inhibitors and EGFR Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Clinical Trials462 topics
  2. Targeted Therapy462 topics
  3. Tumor Microenvironment392 topics
  4. Immune Checkpoint Blockade341 topic
  5. PD-1 and PD-L1341 topic
  6. Chemotherapy334 topics
  7. ALK Inhibitors311 topic
  8. EGFR Mutations311 topic
  9. Metastasis202 topics
  10. Genomic Profiles151 topic
  11. Small-Cell Lung Cancer151 topic
  12. CT Screening81 topic
  13. Lung Cancer81 topic
  14. Breast Cancer51 topic
  15. Cancer51 topic
  16. Cetuximab51 topic
  17. HER251 topic
  18. Inflammation51 topic
  19. KRAS Mutations51 topic
  20. Fibrosis41 topic
  21. Idiopathic Pulmonary Fibrosis41 topic

Where does Jun Sugisaka work?

Jun Sugisaka's main affiliation in the publication record is Sendai Kousei Hospital, Japan.

How many publications and citations does Jun Sugisaka have?

OpenAlex counts 63 works and 1,110 citations for Jun Sugisaka, an h-index of 11, ranking #2,916,104 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jun Sugisaka. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.